CAR-T cells and bispecific antibodies have advanced our therapeutic armamentarium for haematological malignancies. The programme of the ESH 2nd How I Manage "CAR-T Therapies and Bispecific Antibodies for my patients"" conference aims to provide an overview of the benefits and risks of currently available therapies for acute lymphoblastic leukaemia, lymphoma and multiple myeloma. Special focus will be placed on the advantages and disadvantages of bispecific antibodies vs. cellular therapies (including T cells, NK cells and transplant strategies). Future perspectives regarding applications in other haematological malignancies and in solid tumours will also be discussed. Chairs: Ulrich Jäger, Marie José Kersten, Loretta Nastoupil

Date: Friday 29 September - Sunday 1 October 2023
Venue: Vienna House Andels' Berlin, Germany

CAR-T cells and bispecific antibodies have advanced our therapeutic armamentarium for haematological malignancies. The programme of this ESH conference aims to provide an overview of the benefits and risks of currently available therapies for acute lymphoblastic leukaemia, lymphoma and multiple myeloma. Special focus will be placed on the advantages and disadvantages of bispecific antibodies vs. cellular therapies (including T cells, NK cells and transplant strategies). Future perspectives regarding applications in other haematological malignancies and in solid tumours will also be discussed.

The format of the meeting is based on the analysis and discussion of clinical case studies. It will adopt a problem-solving approach, addressing practical considerations and guidelines. Emphasis will be placed on open discussion, including a maximum level of interaction between faculty and registered participants. In addition to the scientific and medical issues addressed during the conference, the questions of affordability of and access to these novel expensive treatments will be tackled by medical experts, representatives of patient organisations, economists, authorities and industry.

Continuing Medical Education (CME) credit points will be awarded to physicians for the time they will spend at the meeting improving their knowledge and skills. ESH is a provider of the European Haematology CME system.

Posters and Brief Oral Communications:

Registered participants are invited to submit their clinical cases and abstracts abstracts. Selected clinical cases and abstracts will be presented as brief oral communications or posters.

Call for abstracts and clinical cases: deadline 2 July 2023

The meeting will be of interest to:

  • Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
  • Junior scientists and clinicians (MD, PhD)
  • PhD candidates and clinical residents still in-training

Learning Objectives:

Upon completion of this CME activity, participants should be able to:

  • Understanding of the current landscape of bispecific antibodies
  • Understanding of the current landscape of CAR-T cells
  • Novel approaches and technologies in the field
  • Integration of novel therapies into current clinical practice
  • Future perspectives in bispecific antibody and cellular therapies in haematological malignancies and solid tumours Scientific

Topics:

  • Diffuse large B-cell Lymphoma: How to optimize the benefit of CAR T-cell therapy?
  • Diffuse large B-cell lymphoma: How to minimize potential risks of CAR T-cell therapy?
  • Multiple Myeloma: targeting BCMA with bispecifics and CARs
  • Bispecific antibodies in the treatment of B-NHL
  • Acute lymphoblastic leukaemia (ALL): the role of CARs and Bispecifics
  • Lessons from paediatric haematology
  • Perspectives: CARs and bispecifics for haematological malignancies

The programme will include:

  • Keynote Lecture
  • Plenary Sessions
  • Meet the Expert Sessions
  • Roundtables
  • Debates
  • Mentored Poster Walks
  • Brief Oral Communications
  • Voting technology

Conference website and registration

External Events

Jun 25
5
6
24
25
Sep 25
26
29
Oct 25
2
10
16
June 5th 2025
Haematological Malignancy Diagnostic Service (H...
The Haematological Malignancy Diagnostic Service (HMDS) Integrated Diagnostic Course is a new innovative two-day cour...
Details
June 6th 2025
UK and Ireland MPN Educational Day...for MPN an...
The aim of this meeting is to bring together the UK and Ireland MPN nursing, pharmacy and AHP community for an educat...
Location: Cavendish Conference Centre
Details
June 24th 2025
What's New In Haematological Malignancies
An expert faculty will deliver a day of lectures and discussions to explore “What’s New in Haematological Malignancie...
Details
June 25th 2025
BSBMTCT Scientific Showcase: Advanced Cellular...
This event will highlight innovation in the field of cellular therapy and is aimed at all healthcare professionals wo...
Location: Cavendish Conference Centre
Details
September 26th 2025
ESH 3rd How I Manage: CAR-T Therapies and Bispe...
"The format of the meeting is based on the analysis and discussion of clinical case studies. It will adopt a problem-...
Details
September 29th 2025
Haematology in Obstetrics course 2025
The Haematology in Obstetrics course aims to develop an understanding of the physiology and pathology of obstetric ha...
Location: St Edmund Hall, Oxford University
Details
October 2nd 2025
ESH 8th Translational Research Conference: Lymp...
"The ESH 8th Translational Research Conference: Lymphoid Malignancies will address the rapidly evolving field of lymp...
Details
October 10th 2025
ESH-iCMLf 27th Annual John Goldman Conference o...
ESH-iCMLf 27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy Chairs: Jorge Corte...
Details
October 16th 2025
ESH 7th International Conference: Acute Myeloid...
"The seventh bi-annual ESH conference in this series will offer discussions on the latest developments and emerging i...
Details